Loading RARE...
Ultragenyx Pharmaceutical Inc.RAREAs of 31 July 2026
Core fundamentals vs overall market
Forward 3-year CAGR·
Gross margin (TTM)·
Net margin (TTM)·
Forward net margin·
−300−1500+150+300
93
PositiveNegative
Positive skew
CheapExpensive
Emotion−56
FearGreed
WeakStrong
Fundamentals

How strong are Ultragenyx Pharmaceutical Inc.'s fundamentals?

A read on the fundamental strength of Ultragenyx Pharmaceutical Inc. (RARE): whether the business underneath the share price is sound or deteriorating, so a low valuation reads as a real opportunity rather than a value trap. Information, not advice.

Ultragenyx Pharmaceutical Inc.RARELast 5 years
VEFA
RARE priceasymmetryquant.com